BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Arcangeli S, Pinzi V, Arcangeli G. Epidemiology of prostate cancer and treatment remarks. World J Radiol 2012; 4(6): 241-246 [PMID: 22778875 DOI: 10.4329/wjr.v4.i6.241]
URL: https://www.wjgnet.com/1007-9327/full/v4/i6/241.htm
Number Citing Articles
1
C R Balistreri, G Candore, D Lio, G Carruba. Prostate cancer: from the pathophysiologic implications of some genetic risk factors to translation in personalized cancer treatmentsCancer Gene Therapy 2014; 21(1): 2 doi: 10.1038/cgt.2013.77
2
Harindra Patel, Patrícia Melo Aguiar, Adalberto Pessoa Jr., Sílvia Storpirtis, Paul F. Long. Identifying quality of life indicators to improve outpatient pharmacy services for prostate cancer patients: a comparison between brazilian and british experiencesInternational braz j urol 2019; 45(3): 435 doi: 10.1590/s1677-5538.ibju.2018.0553
3
Lavínia de C. Brito, Ana Luiza Rangel Berenger, Maria Raquel Figueiredo. An overview of anticancer activity of Garcinia and HypericumFood and Chemical Toxicology 2017; 109: 847 doi: 10.1016/j.fct.2017.03.053
4
Ying Jiang, Hanbing Song, Ling Jiang, Yu Qiao, Dan Yang, Donghua Wang, Ji Li. Silybin Prevents Prostate Cancer by Inhibited the ALDH1A1 Expression in the Retinol Metabolism PathwayFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.574394
5
Vincenza Conteduca, Giuseppe Di Lorenzo, Alfredo Tartarone, Michele Aieta. The cardiovascular risk of gonadotropin releasing hormone agonists in men with prostate cancer: An unresolved controversyCritical Reviews in Oncology/Hematology 2013; 86(1): 42 doi: 10.1016/j.critrevonc.2012.09.008
6
Giedrius Vanagas, Aušra Mickevičienė, Albertas Ulys. Does quality of life of prostate cancer patients differ by stage and treatment?Scandinavian Journal of Public Health 2013; 41(1): 58 doi: 10.1177/1403494812467503
7
Zhongyi Yang, Silong Hu, Jingyi Cheng, Junyan Xu, Wei Shi, Beiling Zhu, Yongping Zhang, Zhifeng Yao, Herong Pan, Yingjian Zhang. Prevalence and risk of cancer of incidental uptake in prostate identified by fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomographyClinical Imaging 2014; 38(4): 470 doi: 10.1016/j.clinimag.2014.01.019
8
Maryam Moossavi, Negin Parsamanesh, Afsane Bahrami, Stephen L. Atkin, Amirhossein Sahebkar. Role of the NLRP3 inflammasome in cancerMolecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0900-3
9
Weibo Xu, Junkai Chang, Guangchao Liu, Xinyi Du, Xiaodong Li. Knockdown of FOXR2 suppresses the tumorigenesis, growth and metastasis of prostate cancerBiomedicine & Pharmacotherapy 2017; 87: 471 doi: 10.1016/j.biopha.2016.12.120
10
Flavia E. Santiano, María de los Ángeles Fernández, Magdalena Espino, Leila E. Zyla, Lara Rey, Silvina E. Gómez, Flavia A. Bruna, Virginia Pistone-Creydt, Elisa Pietrobon, Rafael Pérez Elizalde, María F. Silva, Rubén W. Carón, Constanza M. López Fontana. Protective effects of Yerba mate (IIex paraguariensis) on prostate cancer developmentNutrition 2023; 108: 111957 doi: 10.1016/j.nut.2022.111957
11
SHIREEN PARSAI, RICK KECK, EWA SKRZYPCZAK-JANKUN, JERZY JANKUN. Analysis of the anticancer activity of curcuminoids, thiotryptophan and 4-phenoxyphenol derivativesOncology Letters 2014; 7(1): 17 doi: 10.3892/ol.2013.1679
12
Paulina Koczurkiewicz, Irma Podolak, Joanna Skrzeczyńska-Moncznik, Michał Sarna, Katarzyna Anna Wójcik, Damian Ryszawy, Agnieszka Galanty, Sławomir Lasota, Zbigniew Madeja, Jarosław Czyż, Marta Michalik. Triterpene saponosides from Lysimachia ciliata differentially attenuate invasive potential of prostate cancer cellsChemico-Biological Interactions 2013; 206(1): 6 doi: 10.1016/j.cbi.2013.08.003
13
Ayman EL-Meghawry EL-Kenawy, Snur M.A. Hassan, Hosam-Eldin Hussein Osman. Nonvitamin and Nonmineral Nutritional Supplements2019; : 313 doi: 10.1016/B978-0-12-812491-8.00045-X
14
Yueh Jia Lee, Wei Qi Loh, Trung Kien Dang, Cecilia Woon Chien Teng, Wen-Chi Pan, Chih-Da Wu, Sin Eng Chia, Wei Jie Seow. Determinants of residential greenness and its association with prostate cancer risk: A case-control study in SingaporeEnvironmental Research 2023; 237: 116903 doi: 10.1016/j.envres.2023.116903
15
ILARIA MARECH, ANGELO VACCA, NICOLA SIVESTRIS, ANTONIO GNONI, VITO LORUSSO. Partial response of liver metastases treated with abiraterone in castration-resistant prostate cancer: A case reportOncology Letters 2013; 5(6): 1877 doi: 10.3892/ol.2013.1275
16
Heather R. Banister, Stephen T. Hammond, Shannon K. Parr, Shelbi L. Sutterfield, Vanessa-Rose G. Turpin, Scott Treinen, Martin J. Bell, Carl J. Ade. Lower endothelium-dependent microvascular function in adult breast cancer patients receiving radiation therapyCardio-Oncology 2021; 7(1) doi: 10.1186/s40959-021-00104-z
17
Shilpa Venkatachalam, Danil V. Makarov. Prostate Cancer2016; : 605 doi: 10.1016/B978-0-12-800077-9.00064-5
18
Mariano Garcia-Arranz, Sergio Alonso-Gregorio, Pamela Fontana-Portella, Elena Bravo, Jesus Diez Sebastian, María Eugenia Fernandez-Santos, Damian Garcia-Olmo. Two phase I/II clinical trials for the treatment of urinary incontinence with autologous mesenchymal stem cellsStem Cells Translational Medicine 2020; 9(12): 1500 doi: 10.1002/sctm.19-0431
19
Mingyang Tang, Xiaodong Hu, Yi Wang, Xin Yao, Wei Zhang, Chenying Yu, Fuying Cheng, Jiangyan Li, Qiang Fang. Ivermectin, a potential anticancer drug derived from an antiparasitic drugPharmacological Research 2021; 163: 105207 doi: 10.1016/j.phrs.2020.105207
20
Stephan J. Wu, Daniel O. Villarreal, Devon J. Shedlock, David B. Weiner. Gene Therapy for HIV and Chronic InfectionsAdvances in Experimental Medicine and Biology 2015; 848: 131 doi: 10.1007/978-1-4939-2432-5_7
21
Ambrish A. Pandit, Michael T. Halpern, Laura E Gressler, Mohamed Kamel, Nalin Payakachat, Chenghui Li. Association of race/ethnicity and patient care experiences with receipt of definitive treatment among prostate cancer survivors: a SEER-CAHPS studyCancer Causes & Control 2024; 35(4): 647 doi: 10.1007/s10552-023-01834-4
22
Ramón Virasoro, Mary H. James, Kurt A. McCammon. Evaluation and Management of Rectourethral Fistula Following Radiation Treatment for Prostate CancerCurrent Bladder Dysfunction Reports 2012; 7(4): 275 doi: 10.1007/s11884-012-0154-7